CN115400052B - 一种胭脂树红护肤沙霜及其制备方法 - Google Patents
一种胭脂树红护肤沙霜及其制备方法 Download PDFInfo
- Publication number
- CN115400052B CN115400052B CN202210915434.9A CN202210915434A CN115400052B CN 115400052 B CN115400052 B CN 115400052B CN 202210915434 A CN202210915434 A CN 202210915434A CN 115400052 B CN115400052 B CN 115400052B
- Authority
- CN
- China
- Prior art keywords
- composition
- sodium polyacrylate
- skin
- stirring
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000012730 carminic acid Nutrition 0.000 title claims abstract description 27
- 239000006071 cream Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims abstract description 56
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims abstract description 56
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 30
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 30
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 30
- 239000001168 astaxanthin Substances 0.000 claims abstract description 30
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 30
- 229920002472 Starch Polymers 0.000 claims abstract description 24
- 239000008107 starch Substances 0.000 claims abstract description 24
- 235000019698 starch Nutrition 0.000 claims abstract description 24
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 23
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 23
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 20
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 18
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 16
- 239000003086 colorant Substances 0.000 claims abstract description 14
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims abstract description 12
- 239000003974 emollient agent Substances 0.000 claims abstract description 9
- 229930182478 glucoside Natural products 0.000 claims abstract description 9
- 150000008131 glucosides Chemical class 0.000 claims abstract description 9
- 230000003750 conditioning effect Effects 0.000 claims abstract description 8
- 239000003906 humectant Substances 0.000 claims abstract description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940075529 glyceryl stearate Drugs 0.000 claims abstract description 7
- 229940100460 peg-100 stearate Drugs 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 81
- 238000003756 stirring Methods 0.000 claims description 39
- 239000002994 raw material Substances 0.000 claims description 36
- -1 polydimethylsiloxane Polymers 0.000 claims description 27
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 claims description 25
- 229940093497 ergothioneine Drugs 0.000 claims description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 24
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 24
- 241000246358 Thymus Species 0.000 claims description 23
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 23
- 239000002245 particle Substances 0.000 claims description 23
- 239000001585 thymus vulgaris Substances 0.000 claims description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 22
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 239000011732 tocopherol Substances 0.000 claims description 20
- 229930003799 tocopherol Natural products 0.000 claims description 20
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 19
- 235000019198 oils Nutrition 0.000 claims description 19
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical group CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 18
- 235000010384 tocopherol Nutrition 0.000 claims description 18
- 229960001295 tocopherol Drugs 0.000 claims description 18
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 18
- 244000017106 Bixa orellana Species 0.000 claims description 16
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 16
- 235000012665 annatto Nutrition 0.000 claims description 16
- 239000010362 annatto Substances 0.000 claims description 16
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 16
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 13
- 108010087806 Carnosine Proteins 0.000 claims description 13
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 13
- 229940044199 carnosine Drugs 0.000 claims description 13
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 13
- 230000001804 emulsifying effect Effects 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 244000086363 Pterocarpus indicus Species 0.000 claims description 11
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 claims description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 10
- 239000002562 thickening agent Substances 0.000 claims description 10
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 10
- 241000379194 Abies sibirica Species 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 239000003995 emulsifying agent Substances 0.000 claims description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 8
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 8
- 244000179970 Monarda didyma Species 0.000 claims description 8
- 235000010672 Monarda didyma Nutrition 0.000 claims description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 8
- 241001506047 Tremella Species 0.000 claims description 8
- 229960000458 allantoin Drugs 0.000 claims description 8
- 235000013871 bee wax Nutrition 0.000 claims description 8
- 239000012166 beeswax Substances 0.000 claims description 8
- 239000010645 fir oil Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 8
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 8
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 238000005086 pumping Methods 0.000 claims description 6
- 239000002884 skin cream Substances 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 5
- 241000168517 Haematococcus lacustris Species 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 5
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 5
- 125000005456 glyceride group Chemical group 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 235000020238 sunflower seed Nutrition 0.000 claims description 5
- 229940008099 dimethicone Drugs 0.000 claims description 4
- BLKPFVWYBFDTPX-UHFFFAOYSA-N 2-(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)acetaldehyde Chemical compound C1C2C(C)(C)C1CC=C2CC=O BLKPFVWYBFDTPX-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 240000008607 Opuntia megacantha Species 0.000 claims description 3
- 235000002840 Opuntia megacantha Nutrition 0.000 claims description 3
- 235000006538 Opuntia tuna Nutrition 0.000 claims description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 229940049290 hydrogenated coco-glycerides Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 229940031439 squalene Drugs 0.000 claims description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 3
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 claims description 3
- 238000009736 wetting Methods 0.000 claims description 3
- 235000019149 tocopherols Nutrition 0.000 claims description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims description 2
- 229940072107 ascorbate Drugs 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 1
- CDAISMWEOUEBRE-CDRYSYESSA-N scyllo-inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-CDRYSYESSA-N 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
- 230000000007 visual effect Effects 0.000 abstract description 7
- 241000533793 Tipuana tipu Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 50
- 239000000047 product Substances 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 17
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 102000010638 Kinesin Human genes 0.000 description 4
- 108010063296 Kinesin Proteins 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000004792 oxidative damage Effects 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 2
- 229920002079 Ellagic acid Polymers 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 208000028990 Skin injury Diseases 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000005282 brightening Methods 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960002852 ellagic acid Drugs 0.000 description 2
- 235000004132 ellagic acid Nutrition 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000036252 glycation Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000011506 response to oxidative stress Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种胭脂树红护肤沙霜及其制备方法,包括按照重量百分比计的以下组分:鲸蜡硬脂醇2‑3%,聚丙烯酸钠0.16‑0.18%,聚丙烯酸钠接枝淀粉0.1‑0.3%,鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷1.6‑2.4%,甘油硬脂酸酯/PEG‑100硬脂酸酯1.3‑1.7%,润肤剂5‑9.5%,皮肤调理剂3.5‑6.8%,保湿剂12‑18%,着色剂0.2‑0.3%,成膜剂1.1‑2%,抗氧化剂0.4‑0.6%,水,余量;皮肤调理剂包括红木籽提取物和虾青素。本发明所提供的胭脂树红护肤沙霜具有天然的红色,提供绵密柔润的丝绒肤感,打造出独特的红丝绒视觉外观。
Description
技术领域
本发明涉及化妆品技术领域,尤其涉及一种胭脂树红护肤沙霜及其制备方法。
背景技术
皮肤衰老症状的表现包括皮肤出现色斑、皱纹等,引起皮肤衰老的重要原因包括环境应激导致自由基的积累、角质层过量的自由基积聚等。为了帮助皮肤对抗外界环境及内在产生的氧化压力,在护肤产品中使用抗氧化剂以清除残留在皮肤内过剩的自由基成为了皮肤美容的一个重要部分,而迄今为止用于护肤品中的抗氧化剂多以维生素E、维生素A、维生素C及衍生物等为主。此外,常规护肤膏霜的外观多是光滑细腻有光泽的,缺乏特别之处,难以在外观中脱颖而出。
发明内容
为了克服现有技术的不足,本发明的目的之一在于提供一种胭脂树红护肤沙霜,抗衰老抗氧化,并具有独特的红丝绒视觉外观。
本发明的目的之二在于提供一种胭脂树红护肤沙霜的制备方法,流程简单,产品质量稳定。
本发明的目的之一采用如下技术方案实现:
一种胭脂树红护肤沙霜,包括按照重量百分比计的以下组分:鲸蜡硬脂醇2-3%,聚丙烯酸钠0.16-0.18%,聚丙烯酸钠接枝淀粉0.1-0.3%,鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷1.6-2.4%,甘油硬脂酸酯/PEG-100硬脂酸酯1.3-1.7%,润肤剂5-9.5%,皮肤调理剂3.5-6.8%,保湿剂12-18%,着色剂0.2-0.3%,成膜剂1.1-2%,抗氧化剂0.4-0.6%,水,余量;所述皮肤调理剂包括红木籽提取物和虾青素。
本发明选用不同粒径的聚丙烯酸钠及聚丙烯酸钠接枝淀粉作为水相增稠剂,赋予产品类似豆沙的粉质感,提供绵密柔润的丝绒肤感。同时,提取自胭脂树红色种子的红木籽提取物和虾青素赋予产品一抹天然的红色,施以少量红色色粉定色,打造出独特的红丝绒的视觉外观。
本发明利用胭脂树籽油中的类胡萝卜素、鞣花酸等中和自由基,发挥抗氧化作用,修复因恶劣环境、换季、不健康的作息等造成的肌肤损伤,帮助肌肤抵御外界侵害,提升自我修护力,为疲劳的肌肤补充活力。同时以虾青素、抗坏血酸四异棕榈酸酯、麦角硫因、肌肽、欧百里香提取物等活性物质为协同,达到高效抗氧化抗衰老的功效,使肌肤充满生机、保持年轻态。
本发明采用两种乳化剂进行搭配使用,能够保证产品的稳定性,配方中鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷起主乳化作用,甘油硬脂酸酯/PEG-100硬脂酸酯起助乳化作用。增稠剂鲸蜡硬脂醇也是一种是稳定剂,能够增加护肤品的稳定性,保证产品不易变质。
在本发明的一个实施方式中,所述聚丙烯酸钠和所述聚丙烯酸钠接枝淀粉的粒径不相同。优选地,所述聚丙烯酸钠的粒径为25-400nm;所述聚丙烯酸钠接枝淀粉的粒径为25-400nm,聚丙烯酸钠和聚丙烯酸钠接枝淀粉的粒径较佳范围均为25-400nm,但是在实际配用过程中,它们两者取不同的粒径,如聚丙烯酸钠的粒径取25-50nm,聚丙烯酸钠接枝淀粉的粒径取100-200nm。
不同粒径的聚丙烯酸钠及聚丙烯酸钠接枝淀粉在水中溶胀后,表现出来的粗糙感不一样,粒径大的会相对粗糙,粒径小的相对细腻。两者搭配使用能够使产品同时具有绒感和沙感,又因两者粒径不一样,在使用的时候将其用水溶胀后,能明显感觉到不一样的沙感。
此外,聚丙烯酸钠接枝淀粉、聚丙烯酸钠能带来绒感和沙感,但是它们容易水化,抹一抹就化掉了,导致终产品质感相对较差。本发明复配鲸蜡硬脂醇,能够增加产品的质感,同时也使产品更为稳定。
在本发明的一个实施方式中,所述着色剂为CI77491、鲸蜡基PEG/PPG-10/1聚二甲基硅氧烷和CI77019形成的组合物;所述成膜剂为聚二甲基硅氧烷和聚硅氧烷-11形成的组合物;所述抗氧化剂为对羟基苯乙酮。
本发明的配方中添加成膜剂聚二甲基硅氧烷/聚硅氧烷-11,能使产品在涂抹后期有类似成膜的感觉,从而使皮肤达到一定的紧致感或饱满感。
在本发明的一个实施方式中,所述皮肤调理剂包括鲨肝醇、抗坏血酸四异棕榈酸酯、尿囊素、肌肽、西伯利亚冷杉油、香柠檬果油、胭脂树籽油组合物、麦角硫因组物、虾青素组合物和欧百里香组合物。
在本发明的一个实施方式中,所述胭脂树籽油组合物为向日葵籽油、辛酸/癸酸甘油三酯、红木籽提取物和生育酚形成的组合物;所述麦角硫因组物为甘露糖醇和麦角硫因形成的组合物;所述虾青素组合物为虾青素、雨生红球藻提取物、辛酸/癸酸甘油三酯、生育酚和油菜籽油形成的组合物;所述欧百里香组合物为欧百里香提取物、水和丁二醇形成的组合物。
虾青素、抗坏血酸四异棕榈酸酯、麦角硫因、肌肽、欧百里香提取物等活性物质等都具有一定的抗氧化功效:虾青素捕获细胞内外活性氧、清除自由基,抑制黑色素生成,清空累积氧化损伤;抗坏血酸四异棕榈酸酯抑制细胞内酪氨酸酶活性和黑色素的生成,预防脂类过氧化和皮肤老化;麦角硫因组合物通过清除自由基的强大能力中和体内失衡的氧化应激反应,保护DNA避免环境污染引起的氧化性损伤,同时保护和维持其他抗氧化物质的生物活性;肌肽肌肽通过抑制糖化防止蛋白质的破坏,同时保护细胞膜的脂类成分;欧百里香通过减少黑色素细胞内的驱动蛋白的量来抑制黑色素被搬运,同时抑制驱动蛋白的活性,是肌肤亮白,减少色斑。
本发明将从热带红木科属的红木种子中提取的活性护肤成分,与产自酷寒极地的西伯利亚冷杉散发的清凉木质香气相结合;与此同时,产品火红色的外观搭配冬日森林的气息,给人一种暖冬里沐浴森林的感觉,令人耳目一新、舒适自然。
在本发明的一个实施方式中,所述润肤剂选自以下中的一种或任意组合:氢化椰油甘油酯类、蜂蜡、鲸蜡醇乙基己酸酯、聚二甲基硅氧烷、聚二甲基硅氧烷醇、环己硅氧烷、环五聚二甲基硅氧烷、碳酸二辛酯和生育酚。
在本发明的一个实施方式中,所述保湿剂选自以下中的一种或任意组合:甘油、丁二醇、透明质酸钠、银耳子实体提取物、聚丙烯酸钠、丙二醇、1,2-己二醇和1,2-戊二醇。
在本发明的一个实施方式中,所述胭脂树红护肤沙霜包括按照重量百分比计的以下组分:
增稠剂:鲸蜡硬脂醇2-3%,聚丙烯酸钠0.16-0.18%,聚丙烯酸钠接枝淀粉0.1-0.3%;
乳化剂:鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷1.6-2.4%,甘油硬脂酸酯/PEG-100硬脂酸酯1.3-1.7%,
润肤剂:氢化椰油甘油酯类0.2-0.5%、蜂蜡1.3-1.6%、鲸蜡醇乙基己酸酯1-4%、聚二甲基硅氧烷0.3-0.5%、聚二甲基硅氧烷醇0.01-0.11%、环己硅氧烷0.5-0.7%、环五聚二甲基硅氧烷1.3-1.5%、碳酸二辛酯0.4-0.5%,生育酚0.0002-0.003%,
皮肤调理剂:鲨肝醇0.2-0.3%、抗坏血酸四异棕榈酸酯0.14-0.15%、、胭脂树籽油组合物2-3.5%、尿囊素0.15-0.26%、麦角硫因组物0.09-0.11%、肌肽0.1-0.3%、虾青素组合物0.8-1.2%、欧百里香组合物0.4-0.6%、西伯利亚冷杉油0.07-0.08%、香柠檬果油0.01-0.03%;所述胭脂树籽油组合物为向日葵籽油、辛酸/癸酸甘油三酯、红木籽提取物和生育酚形成的组合物;所述麦角硫因组物为甘露糖醇和麦角硫因形成的组合物;所述虾青素组合物为虾青素、雨生红球藻提取物、辛酸/癸酸甘油三酯、生育酚和油菜籽油形成的组合物;所述欧百里香组合物为欧百里香提取物、水和丁二醇形成的组合物;
保湿剂:甘油7.6-8%,丁二醇2-4%,透明质酸钠0.06-0.6%,银耳子实体提取物0.03-0.04%,聚丙烯酸钠0.8-1.0%,丙二醇1-3%,1,2-己二醇0.4-0.6%,1,2-戊二醇0.2-0.4%;
着色剂:CI77491、鲸蜡基PEG/PPG-10/1聚二甲基硅氧烷和CI77019形成的组合物0.2-0.3%;
成膜剂:聚二甲基硅氧烷和聚硅氧烷-11形成的组合物1.1-2%;
抗氧化剂:对羟基苯乙酮0.4-0.6%;
溶剂:水,余量。
本发明所提供的胭脂树红护肤沙霜,配方中使用了较多量的胭脂树籽油组合物、虾青素、维生素C衍生物等,产品易出现色泽不稳定的情况,如变色、褪色等情况,这是比较难克服的难题,申请人经过大量研发,找到了相对合适的解决办法,包括a、加适量着色剂定色;b、加入抗氧化剂对羟基苯乙酮,同时配方原料中本身复配了一定量的生育酚,添加的麦角硫因也可以起到抗氧化作用;c、设计配方时,产品pH尽量控制在6以下(本发明的配方多用中性原料及弱酸性原料);d、制备工艺方面需要避免长时间受热。
本发明的目的之二采用如下技术方案实现:
一种胭脂树红护肤沙霜的制备方法,包括以下步骤:
将原料润肤剂环己硅氧烷、环五聚二甲基硅氧烷、碳酸二辛酯、生育酚和着色剂混合润湿,并研磨均匀细腻,待用,形成A2相;
将鲸蜡硬脂醇、氢化椰油甘油酯类、蜂蜡、鲸蜡醇乙基己酸酯和乳化剂加入油锅,搅拌加热到80-85℃,至完全溶解无颗粒后,加入A1相原料成膜剂、聚二甲基硅氧烷以及聚二甲基硅氧烷醇,搅拌分散均匀,形成A3相;加入预处理好的A2相,搅拌分散均匀,恒温84~80℃,形成A4相,待用;
抽油操作前,往A4相中加入A5相原料鲨肝醇、抗坏血酸四异棕榈酸酯和胭脂树籽油组合物,搅拌溶解完全,形成A相;
将B相原料包括部分水、甘油、部分丁二醇、尿囊素、聚丙烯酸钠接枝淀粉、透明质酸钠和银耳子实体提取物加入乳化锅,分散均匀后,搅拌加热至85-88℃,均质3-5分钟,至溶解完全均匀透明无颗粒;依次加入预先分散均匀的B1相原料聚丙烯酸钠和部分丙二醇,以及B2相原料部分丙二醇和聚丙烯酸钠,搅拌均匀,继续均质1-2分钟;
快速搅拌下将A相缓慢抽入乳化锅,均质5-8分钟;保温25-18分钟后搅拌降温至68-62℃;
将C相原料部分丁二醇、对羟基苯乙酮和1,2-己二醇单独加热到60-65℃,搅拌溶解完全透明无颗粒,待乳化锅中料体降温至66-62℃时加入乳化锅中,搅拌均匀;
继续搅拌降温至55-50℃,加入预先溶解完全的C1相原料部分水、部分丁二醇、麦角硫因组物和肌肽,搅拌均匀;
继续降温至50-45℃,依次加入D相原料虾青素组合物、1,2-戊二醇、欧百里香组合物、西伯利亚冷杉油和香柠檬果油,搅拌均匀;
最后得到胭脂树红护肤沙霜。
相比现有技术,本发明的有益效果在于:
(1)本发明所提供的胭脂树红护肤沙霜,是一种丝绒护肤沙霜,其选用聚丙烯酸钠及聚丙烯酸钠接枝淀粉作为水相增稠剂,能够赋予产品类似豆沙的粉质感,提供绵密柔润的丝绒肤感。同时,提取自胭脂树红色种子的红木籽提取物和虾青素能够赋予产品一抹天然的红色,打造出独特的红丝绒的视觉外观。本发明利用胭脂树籽油中的类胡萝卜素、鞣花酸等中和自由基,发挥抗氧化作用,修复因恶劣环境、换季、不健康的作息等造成的肌肤损伤,帮助肌肤抵御外界侵害,提升自我修护力,为疲劳的肌肤补充活力。同时以虾青素等活性物质发挥高效的抗氧化抗衰老的功效,使肌肤充满生机、保持年轻态。
(2)本发明所提供的胭脂树红护肤沙霜的制备方法,流程简单,产品质量易控,所获得的护肤沙霜绵软有粉质感、同时具有丝绒般绒感,此独特的外观可赋予膏体一种朦胧自然的新颖与时尚感,具有良好的市场前景。
附图说明
图1为本发明实施例1所提供的胭脂树红护肤沙霜的产品示意图;
图2为本发明实施例1所提供的胭脂树红护肤沙霜的铺展示意图。
具体实施方式
下面,结合附图以及具体实施方式,对本发明做进一步描述,需要说明的是,在不相冲突的前提下,以下描述的各实施例之间或各技术特征之间可以任意组合形成新的实施例。在下述实施例中所采用的原材料、设备等除特殊限定外均可以通过购买方式获得。
实施例1-3
一种胭脂树红护肤沙霜,由保湿剂、润肤剂、增稠剂、乳化剂、皮肤调理剂、抗氧化剂、成膜剂等原料制备而成,具体详见表1和表2。在本发明实施例中,聚丙烯酸钠的粒径为25-50nm;聚丙烯酸钠接枝淀粉的粒径为100-200nm。
表1实施例1-3胭脂树红护肤沙霜的配方表
表2配方中部分原料的具体信息
表格中,同个序号的原料代表一种原料,其是一种复配好的组合物,例如5号乳化剂原料鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷,其是由鲸蜡硬脂醇和鲸蜡硬脂基葡糖苷形成的组合物,可以直接购买自广州市百好博有限公司。
实施例1-3的胭脂树红护肤沙霜按照以下方法制备而成:
将原料润肤剂环己硅氧烷、环五聚二甲基硅氧烷、碳酸二辛酯、生育酚和着色剂混合润湿,并研磨均匀细腻,待用,形成A2相;
将鲸蜡硬脂醇、氢化椰油甘油酯类、蜂蜡、鲸蜡醇乙基己酸酯和乳化剂加入油锅,搅拌加热到80-85℃,至完全溶解无颗粒后,加入A1相原料成膜剂、聚二甲基硅氧烷以及聚二甲基硅氧烷醇,搅拌分散均匀,形成A3相;加入预处理好的A2相,搅拌分散均匀,恒温82℃,形成A4相,待用;
抽油操作前,往A4相中加入A5相原料鲨肝醇、抗坏血酸四异棕榈酸酯和胭脂树籽油组合物,搅拌溶解完全,形成A相;
将B相原料包括部分水、甘油、部分丁二醇、尿囊素、聚丙烯酸钠接枝淀粉、透明质酸钠和银耳子实体提取物加入乳化锅,分散均匀后,搅拌加热至85-88℃,均质4分钟,至溶解完全均匀透明无颗粒;依次加入预先分散均匀的B1相原料聚丙烯酸钠和部分丙二醇,以及B2相原料部分丙二醇和聚丙烯酸钠,搅拌均匀,继续均质1.5分钟;
快速搅拌下将A相缓慢抽入乳化锅,均质6.5分钟;保温20分钟后搅拌降温至65℃;
将C相原料部分丁二醇、对羟基苯乙酮和1,2-己二醇单独加热到60-65℃,搅拌溶解完全透明无颗粒,待乳化锅中料体降温至66-62℃时加入乳化锅中,搅拌均匀;
继续搅拌降温至50℃,加入预先溶解完全的C1相原料部分水、部分丁二醇、麦角硫因组物和肌肽,搅拌均匀;
继续降温至45℃,依次加入D相原料虾青素组合物、1,2-戊二醇、欧百里香组合物、西伯利亚冷杉油和香柠檬果油,搅拌均匀;
最后得到胭脂树红护肤沙霜。
对比例1
对比例1与实施例1的不同之处在于,省略增稠剂鲸蜡硬脂醇,其余与实施例1相同。
对比例2
对比例2与实施例1的不同之处在于,采用相同粒径的聚丙烯酸钠和聚丙烯酸钠接枝淀粉,它们的粒径均为25-50nm,其余与实施例1相同。
对比例3
对比例3与实施例1的不同之处在于,省略着色剂,其余与实施例1相同。
对比例4
对比了4与实施例1的不同之处在于,省略15号原料生育酚和20号原料麦角硫因组物,其余与实施例1相同。
对比例5
对比例5与实施例1的不同之处在于,省略了22号原料虾青素组合物,其余与实施例1相同。
效果评价及性能检测
1、外观测试
肉眼观察测试样品在不同条件下的外观,包括质感以及颜色,记录于表3。
表3外观测试结果记录表
从表3中可得,实施例1-3的样品稳定性较佳,呈现胭脂树红色,豆沙粉质感,红丝绒视觉外观(实施例1的产品图如图1-2所示)。而对比例的色泽、丝绒感均不如实施例,特别是对比例1,缺了增稠剂鲸蜡硬脂醇,样品的稳定性最差。对比例3缺了着色剂进行定色,产品的颜色不稳定。
2、试用评价
选取80名皮肤健康的试用者,平均分成8组,每组10名,每组试用者分别试用实施例1-3和对比例1-5的样品。在试用时,试用者经过相同的脸部清洁程序后,擦干脸部水分,分别取3g样品,均匀涂抹于脸部皮肤,并按摩2分钟。早晚各使用2次,连续使用21天。试用结束后,试用者分别从不同的指标对样品进行打分,分数为1-10分,分数越高,评价越好,每个指标的分值均取10名试用者的平均分。
表4试用结果记录表
本发明实施例1-3的护肤样品采用不同粒径的聚丙烯酸钠及聚丙烯酸钠接枝淀粉进行复配,能使产品同时具有丝绒感和沙感,它们的粒径不一样,试用者在使用的时候,能明显感觉到不一样的沙质感。同时,配方采用多种皮肤调理剂进行搭配,试用者试用21天后,能够明显感觉到皮肤变细腻光滑了,细纹有所改善,其中虾青素、抗坏血酸四异棕榈酸酯、麦角硫因、肌肽、欧百里香提取物等活性物质等都具有一定的抗氧化功效:虾青素能捕获细胞内外活性氧、清除自由基,抑制黑色素生成,清空累积氧化损伤;抗坏血酸四异棕榈酸酯抑制细胞内酪氨酸酶活性和黑色素的生成,预防脂类过氧化和皮肤老化;麦角硫因通过清除自由基的强大能力中和体内失衡的氧化应激反应,保护DNA避免环境污染引起的氧化性损伤,同时保护和维持其他抗氧化物质的生物活性;肌肽肌肽通过抑制糖化防止蛋白质的破坏,同时保护细胞膜的脂类成分;欧百里香通过减少黑色素细胞内的驱动蛋白的量来抑制黑色素被搬运,同时抑制驱动蛋白的活性,是肌肤亮白,减少色斑。
对比例1省略了增稠剂鲸蜡硬脂醇,样品的豆沙粉质感和绵密柔润的丝绒肤感变差;对比例2采用相同粒径的聚丙烯酸钠及聚丙烯酸钠接枝淀粉进行复配,丝绒感和沙感评价最低。对比例4和对比例5省略了部分皮肤调理剂,抗氧化抗衰老效果变差,具体表现为平滑细腻、细纹改善度的评分较低。
上述实施方式仅为本发明的优选实施方式,不能以此来限定本发明保护的范围,本领域的技术人员在本发明的基础上所做的任何非实质性的变化及替换均属于本发明所要求保护的范围。
Claims (7)
1.一种胭脂树红护肤沙霜,其特征在于,包括按照重量百分比计的以下组分:鲸蜡硬脂醇2-3%,聚丙烯酸钠0.16-0.18%,聚丙烯酸钠接枝淀粉0.1-0.3%,鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷1.6-2.4%,甘油硬脂酸酯/PEG-100 硬脂酸酯1.3-1.7%,润肤剂5-9.5%,皮肤调理剂3.5-6.8%,保湿剂12-18%,着色剂0.2-0.3%,成膜剂1.1-2%,抗氧化剂0.4-0.6%,水余量;
所述皮肤调理剂包括鲨肝醇、抗坏血酸四异棕榈酸酯、尿囊素、肌肽、西伯利亚冷杉油、香柠檬果油、胭脂树籽油组合物、麦角硫因组物、虾青素组合物和欧百里香组合物;所述胭脂树籽油组合物为向日葵籽油、辛酸/癸酸甘油三酯、红木籽提取物和生育酚形成的组合物;所述麦角硫因组物为甘露糖醇和麦角硫因形成的组合物;所述虾青素组合物为虾青素、雨生红球藻提取物、辛酸/癸酸甘油三酯、生育酚和油菜籽油形成的组合物;所述欧百里香组合物为欧百里香提取物、水和丁二醇形成的组合物;
所述着色剂为CI 77491、鲸蜡基 PEG/PPG-10/1 聚二甲基硅氧烷和CI 77019形成的组合物;
所述聚丙烯酸钠的粒径为25-50nm;所述聚丙烯酸钠接枝淀粉的粒径为100-200nm。
2.如权利要求1所述的胭脂树红护肤沙霜,其特征在于,所述成膜剂为聚二甲基硅氧烷和聚硅氧烷-11形成的组合物;所述抗氧化剂为对羟基苯乙酮。
3.如权利要求1所述的胭脂树红护肤沙霜,其特征在于,所述润肤剂选自以下中的一种或任意组合:氢化椰油甘油酯类、蜂蜡、鲸蜡醇乙基己酸酯、聚二甲基硅氧烷、聚二甲基硅氧烷醇、环己硅氧烷、环五聚二甲基硅氧烷、碳酸二辛酯和生育酚。
4.如权利要求1所述的胭脂树红护肤沙霜,其特征在于,所述保湿剂选自以下中的一种或任意组合:甘油、丁二醇、透明质酸钠、银耳子实体提取物、聚丙烯酸钠、丙二醇、1,2-己二醇和1,2-戊二醇。
5.如权利要求1所述的胭脂树红护肤沙霜,其特征在于,包括按照重量百分比计的以下组分:
增稠剂:鲸蜡硬脂醇2-3%,聚丙烯酸钠0.16-0.18%,聚丙烯酸钠接枝淀粉0.1-0.3%;
乳化剂:鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷1.6-2.4%,甘油硬脂酸酯/PEG-100 硬脂酸酯1.3-1.7%,
润肤剂:氢化椰油甘油酯类0.2-0.5%、蜂蜡1.3-1.6%、鲸蜡醇乙基己酸酯1-4%、聚二甲基硅氧烷0.3-0.5%、聚二甲基硅氧烷醇0.01-0.11%、环己硅氧烷0.5-0.7%、环五聚二甲基硅氧烷1.3-1.5%、碳酸二辛酯0.4-0.5%,生育酚0.0002-0.003%,
皮肤调理剂:鲨肝醇0.2-0.3%、抗坏血酸四异棕榈酸酯0.14-0.15%、、胭脂树籽油组合物2-3.5%、尿囊素0.15-0.26%、麦角硫因组物0.09-0.11%、肌肽0.1-0.3%、虾青素组合物0.8-1.2%、欧百里香组合物0.4-0.6%、西伯利亚冷杉油0.07-0.08%、香柠檬果油0.01-0.03%;所述胭脂树籽油组合物为向日葵籽油、辛酸/癸酸甘油三酯、红木籽提取物和生育酚形成的组合物;所述麦角硫因组物为甘露糖醇和麦角硫因形成的组合物;所述虾青素组合物为虾青素、雨生红球藻提取物、辛酸/癸酸甘油三酯、生育酚和油菜籽油形成的组合物;所述欧百里香组合物为欧百里香提取物、水和丁二醇形成的组合物;
保湿剂:甘油7.6-8%,丁二醇2-4%,透明质酸钠0.06-0.6%,银耳子实体提取物0.03-0.04%,聚丙烯酸钠0.8-1.0%,丙二醇1-3%,1,2-己二醇0.4-0.6%,1,2-戊二醇0.2-0.4%;
着色剂:CI 77491、鲸蜡基 PEG/PPG-10/1 聚二甲基硅氧烷和CI 77019形成的组合物0.2-0.3%;
成膜剂:聚二甲基硅氧烷和聚硅氧烷-11形成的组合物1.1-2%;
抗氧化剂:对羟基苯乙酮0.4-0.6%;
溶剂:水余量。
6.如权利要求1所述的胭脂树红护肤沙霜,其特征在于,包括按照重量百分比计的以下组分:
增稠剂:鲸蜡硬脂醇2%,聚丙烯酸钠0.18%,聚丙烯酸钠接枝淀粉0.2%;
乳化剂:鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷2%,甘油硬脂酸酯/PEG-100 硬脂酸酯1.5%,
润肤剂:氢化椰油甘油酯类0.5%、蜂蜡1.5%、鲸蜡醇乙基己酸酯2%、聚二甲基硅氧烷0.4%、聚二甲基硅氧烷醇0.1%、环己硅氧烷0.6%、环五聚二甲基硅氧烷1.4%、碳酸二辛酯0.49975%,生育酚0.00025%,
皮肤调理剂:鲨肝醇0.3%、抗坏血酸四异棕榈酸酯0.15%、胭脂树籽油组合物3%、尿囊素0.25%、麦角硫因组物0.1%、肌肽0.2%、虾青素组合物1%、欧百里香组合物0.5%、西伯利亚冷杉油0.08%、香柠檬果油0.02%;所述胭脂树籽油组合物为向日葵籽油、辛酸/癸酸甘油三酯、红木籽提取物和生育酚形成的组合物;所述麦角硫因组物为甘露糖醇和麦角硫因形成的组合物;所述虾青素组合物为虾青素、雨生红球藻提取物、辛酸/癸酸甘油三酯、生育酚和油菜籽油形成的组合物;所述欧百里香组合物为欧百里香提取物、水和丁二醇形成的组合物;
保湿剂:甘油7.976%,丁二醇3%,透明质酸钠0.05%,银耳子实体提取物0.02%,聚丙烯酸钠0.9%,丙二醇2%,1,2-己二醇0.5%,1,2-戊二醇0.3%;
着色剂:CI 77491、鲸蜡基 PEG/PPG-10/1 聚二甲基硅氧烷和CI 77019形成的组合物0.3%;
成膜剂:聚二甲基硅氧烷和聚硅氧烷-11形成的组合物1.5%;
抗氧化剂:对羟基苯乙酮0.5%;
溶剂:水余量。
7.一种如权利要求5或6所述的胭脂树红护肤沙霜的制备方法,其特征在于,包括以下步骤:
将原料润肤剂环己硅氧烷、环五聚二甲基硅氧烷、碳酸二辛酯、生育酚和着色剂混合润湿,并研磨均匀细腻,待用,形成A2相;
将鲸蜡硬脂醇、氢化椰油甘油酯类、蜂蜡、鲸蜡醇乙基己酸酯和乳化剂加入油锅,搅拌加热到80-85℃,至完全溶解无颗粒后,加入A1相原料成膜剂、聚二甲基硅氧烷以及聚二甲基硅氧烷醇,搅拌分散均匀,形成A3相;加入预处理好的A2相,搅拌分散均匀,恒温84~80℃,形成A4相,待用;
抽油操作前,往A4相中加入A5相原料鲨肝醇、抗坏血酸四异棕榈酸酯和胭脂树籽油组合物,搅拌溶解完全,形成A相;
将B相原料包括部分水、甘油、部分丁二醇、尿囊素、聚丙烯酸钠接枝淀粉、透明质酸钠和银耳子实体提取物加入乳化锅,分散均匀后,搅拌加热至85-88℃,均质3-5分钟,至溶解完全均匀透明无颗粒;依次加入预先分散均匀的B1相原料聚丙烯酸钠和部分丙二醇,以及B2相原料部分丙二醇和聚丙烯酸钠,搅拌均匀,继续均质1-2分钟;
快速搅拌下将A相缓慢抽入乳化锅,均质5-8分钟;保温25-18分钟后搅拌降温至68-62℃;
将C相原料部分丁二醇、对羟基苯乙酮和1,2-己二醇单独加热到60-65℃,搅拌溶解完全透明无颗粒,待乳化锅中料体降温至66-62℃时加入乳化锅中,搅拌均匀;
继续搅拌降温至55-50℃,加入预先溶解完全的C1相原料部分水、部分丁二醇、麦角硫因组物和肌肽,搅拌均匀;
继续降温至50-45℃,依次加入D相原料虾青素组合物、1,2-戊二醇、欧百里香组合物、西伯利亚冷杉油和香柠檬果油,搅拌均匀;
最后得到胭脂树红护肤沙霜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210915434.9A CN115400052B (zh) | 2022-07-31 | 2022-07-31 | 一种胭脂树红护肤沙霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210915434.9A CN115400052B (zh) | 2022-07-31 | 2022-07-31 | 一种胭脂树红护肤沙霜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115400052A CN115400052A (zh) | 2022-11-29 |
CN115400052B true CN115400052B (zh) | 2023-10-10 |
Family
ID=84159190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210915434.9A Active CN115400052B (zh) | 2022-07-31 | 2022-07-31 | 一种胭脂树红护肤沙霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115400052B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116077391B (zh) * | 2023-01-10 | 2024-03-26 | 娇时日化(杭州)股份有限公司 | 一种多用化妆膏及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109984954A (zh) * | 2019-05-20 | 2019-07-09 | 朱颖栋 | 一种骨胶原霜配方及生产工艺 |
CN112603870A (zh) * | 2021-01-28 | 2021-04-06 | 广州希施尔化妆品有限公司 | 一种多效精华霜及其制备方法 |
CN113057923A (zh) * | 2021-04-13 | 2021-07-02 | 东晟源研究院(广州)有限公司 | 用于皮肤清洁护理的凝霜 |
CN113750019A (zh) * | 2021-09-02 | 2021-12-07 | 植然天成(北京)生物科技有限公司 | 一种三七泥状面膜及其制备方法 |
CN114632028A (zh) * | 2022-03-30 | 2022-06-17 | 广州优肌源化妆品有限公司 | 一种提拉紧致面霜及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3313534A1 (en) * | 2015-06-29 | 2018-05-02 | The Procter and Gamble Company | Superabsorbent polymers and starch powders for use in skin care compositions |
-
2022
- 2022-07-31 CN CN202210915434.9A patent/CN115400052B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109984954A (zh) * | 2019-05-20 | 2019-07-09 | 朱颖栋 | 一种骨胶原霜配方及生产工艺 |
CN112603870A (zh) * | 2021-01-28 | 2021-04-06 | 广州希施尔化妆品有限公司 | 一种多效精华霜及其制备方法 |
CN113057923A (zh) * | 2021-04-13 | 2021-07-02 | 东晟源研究院(广州)有限公司 | 用于皮肤清洁护理的凝霜 |
CN113750019A (zh) * | 2021-09-02 | 2021-12-07 | 植然天成(北京)生物科技有限公司 | 一种三七泥状面膜及其制备方法 |
CN114632028A (zh) * | 2022-03-30 | 2022-06-17 | 广州优肌源化妆品有限公司 | 一种提拉紧致面霜及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115400052A (zh) | 2022-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105769666B (zh) | 一种组合物及含有该组合物的护肤品 | |
CN110974767A (zh) | 用于皮肤屏障再生修复的组合物及其应用 | |
CN109674687B (zh) | 一种乳化口红及其制备方法 | |
CN110721120A (zh) | 一种多功能护肤膏及其制备方法 | |
KR101917774B1 (ko) | 블랙커민씨드 추출물을 유효성분으로 포함하는 화장품 보존용 조성물 | |
JP2009242296A (ja) | メラニン産性抑制剤・コラーゲン産生促進剤 | |
CN115400052B (zh) | 一种胭脂树红护肤沙霜及其制备方法 | |
CN109199987A (zh) | 一种含椰子活性物的修护面膜液及其制备方法 | |
KR100994987B1 (ko) | 피부 진정 효과를 가지는 화장료 조성물 | |
CN111265434A (zh) | 一种植物来源乳化剂油包水膏霜及其制备方法 | |
CN104188859B (zh) | 一种含天然成分提取物的抗皱嫩肤乳液及其制备方法 | |
CN113081942A (zh) | 一种含有苹果干细胞的多维水合霜 | |
CN112402335A (zh) | 一种爆水散粉及其制备方法 | |
CN112236201B (zh) | 红木(bixa orellana)提取物的用途 | |
WO2014167557A1 (en) | Cosmetic topical skin treatment formulation | |
JP5888563B2 (ja) | 保湿剤、肌荒れ改善剤、角層水分量増加剤、血流改善剤及び肌のくすみ、くま又はつや改善剤 | |
KR102114246B1 (ko) | 흑효모 발효 작약꽃 초음파 추출물을 함유하는 피부보호용 화장료 조성물 | |
WO2011113785A2 (en) | A cosmetic composition for rejuvenating skin appearance | |
KR101843976B1 (ko) | 흑효모 발효 발아녹두 추출물을 유효성분으로 함유하는 화장료 조성물 | |
CN108158960A (zh) | 具有缓解色素沉着作用的护唇口红 | |
KR102135551B1 (ko) | 포름오노네틴을 지표성분으로 포함하는 레드 프로폴리스 추출물을 포함하는 안티에이징 효과가 우수한 화장료 조성물 | |
KR102308766B1 (ko) | 감태, 톳, 개청각, 우뭇가사리, 제주진득찰 및 랍도시아루베스켄스의 혼합 추출물을 유효성분으로 함유하는 피부 보습용 화장료 조성물 | |
CN111184655B (zh) | 一种皮肤修复组合物、其制备方法及应用 | |
CN115252458A (zh) | 含蓝铜肽的稳定保湿组合物 | |
KR101557422B1 (ko) | 때죽나무 추출물을 유효성분으로 함유하는 세정 또는 세척제 조성물 및 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |